▶ 調査レポート

イマチニブメシル酸塩の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Imatinib Mesylate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。イマチニブメシル酸塩の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Imatinib Mesylate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-08447資料のイメージです。• レポートコード:D005-08447
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール
• 産業分類:化学・材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、イマチニブメシル酸塩の世界市場を広く調査・分析し、今後の市場展望をまとめております。イマチニブメシル酸塩の種類別市場規模(純度99%、純度98%、その他)、用途別市場規模(CML、GIST、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GLEEVEC、Nanjing Kaihua Chemical、Cayman Chemical、Sichuan Xieli、Zhengda Tianqing
・地域別グローバル市場分析 2015年-2020年
・イマチニブメシル酸塩の北米市場(アメリカ、カナダ、メキシコ)
・イマチニブメシル酸塩のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・イマチニブメシル酸塩のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・イマチニブメシル酸塩の南米市場(ブラジル、アルゼンチン)
・イマチニブメシル酸塩の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:純度99%、純度98%、その他
・用途別分析:CML、GIST、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Imatinib Mesylate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Imatinib Mesylate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Imatinib Mesylate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Imatinib Mesylate market has been segmented into
99% Purity
98% Purity
Other

By Application, Imatinib Mesylate has been segmented into:
CML
GIST
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Imatinib Mesylate market presented in the report. This section sheds light on the sales growth of different regional and country-level Imatinib Mesylate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Imatinib Mesylate market.

The report offers in-depth assessment of the growth and other aspects of the Imatinib Mesylate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Imatinib Mesylate Market Share Analysis
Imatinib Mesylate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Imatinib Mesylate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Imatinib Mesylate sales, revenue and market share for each player covered in this report.

The major players covered in Imatinib Mesylate are:
GLEEVEC
Nanjing Kaihua Chemical
Cayman Chemical
Sichuan Xieli
Zhengda Tianqing

Among other players domestic and global, Imatinib Mesylate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Imatinib Mesylate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Imatinib Mesylate, with price, sales, revenue and global market share of Imatinib Mesylate in 2018 and 2019.
Chapter 3, the Imatinib Mesylate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imatinib Mesylate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Imatinib Mesylate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Imatinib Mesylate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Imatinib Mesylate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imatinib Mesylate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 99% Purity
1.2.3 98% Purity
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Imatinib Mesylate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 CML
1.3.3 GIST
1.3.4 Other
1.4 Overview of Global Imatinib Mesylate Market
1.4.1 Global Imatinib Mesylate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GLEEVEC
2.1.1 GLEEVEC Details
2.1.2 GLEEVEC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GLEEVEC SWOT Analysis
2.1.4 GLEEVEC Product and Services
2.1.5 GLEEVEC Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nanjing Kaihua Chemical
2.2.1 Nanjing Kaihua Chemical Details
2.2.2 Nanjing Kaihua Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nanjing Kaihua Chemical SWOT Analysis
2.2.4 Nanjing Kaihua Chemical Product and Services
2.2.5 Nanjing Kaihua Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cayman Chemical
2.3.1 Cayman Chemical Details
2.3.2 Cayman Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cayman Chemical SWOT Analysis
2.3.4 Cayman Chemical Product and Services
2.3.5 Cayman Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sichuan Xieli
2.4.1 Sichuan Xieli Details
2.4.2 Sichuan Xieli Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sichuan Xieli SWOT Analysis
2.4.4 Sichuan Xieli Product and Services
2.4.5 Sichuan Xieli Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zhengda Tianqing
2.5.1 Zhengda Tianqing Details
2.5.2 Zhengda Tianqing Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zhengda Tianqing SWOT Analysis
2.5.4 Zhengda Tianqing Product and Services
2.5.5 Zhengda Tianqing Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Imatinib Mesylate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Imatinib Mesylate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Imatinib Mesylate Manufacturer Market Share in 2019
3.3.2 Top 6 Imatinib Mesylate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Imatinib Mesylate Sales, Revenue and Market Share by Regions
4.1.1 Global Imatinib Mesylate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Imatinib Mesylate Revenue and Market Share by Regions (2015-2020)
4.2 North America Imatinib Mesylate Sales and Growth Rate (2015-2020)
4.3 Europe Imatinib Mesylate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Imatinib Mesylate Sales and Growth Rate (2015-2020)
4.5 South America Imatinib Mesylate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Imatinib Mesylate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Imatinib Mesylate Sales, Revenue and Market Share by Country
5.1.1 North America Imatinib Mesylate Sales and Market Share by Country (2015-2020)
5.1.2 North America Imatinib Mesylate Revenue and Market Share by Country (2015-2020)
5.2 United States Imatinib Mesylate Sales and Growth Rate (2015-2020)
5.3 Canada Imatinib Mesylate Sales and Growth Rate (2015-2020)
5.4 Mexico Imatinib Mesylate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Imatinib Mesylate Sales, Revenue and Market Share by Country
6.1.1 Europe Imatinib Mesylate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Imatinib Mesylate Revenue and Market Share by Country (2015-2020)
6.2 Germany Imatinib Mesylate Sales and Growth Rate (2015-2020)
6.3 UK Imatinib Mesylate Sales and Growth Rate (2015-2020)
6.4 France Imatinib Mesylate Sales and Growth Rate (2015-2020)
6.5 Russia Imatinib Mesylate Sales and Growth Rate (2015-2020)
6.6 Italy Imatinib Mesylate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Imatinib Mesylate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Imatinib Mesylate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Imatinib Mesylate Revenue and Market Share by Regions (2015-2020)
7.2 China Imatinib Mesylate Sales and Growth Rate (2015-2020)
7.3 Japan Imatinib Mesylate Sales and Growth Rate (2015-2020)
7.4 Korea Imatinib Mesylate Sales and Growth Rate (2015-2020)
7.5 India Imatinib Mesylate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Imatinib Mesylate Sales and Growth Rate (2015-2020)
7.7 Australia Imatinib Mesylate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Imatinib Mesylate Sales, Revenue and Market Share by Country
8.1.1 South America Imatinib Mesylate Sales and Market Share by Country (2015-2020)
8.1.2 South America Imatinib Mesylate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Imatinib Mesylate Sales and Growth Rate (2015-2020)
8.3 Argentina Imatinib Mesylate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Imatinib Mesylate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Imatinib Mesylate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Imatinib Mesylate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Imatinib Mesylate Sales and Growth Rate (2015-2020)
9.3 Turkey Imatinib Mesylate Sales and Growth Rate (2015-2020)
9.4 Egypt Imatinib Mesylate Sales and Growth Rate (2015-2020)
9.5 South Africa Imatinib Mesylate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Imatinib Mesylate Sales and Market Share by Type (2015-2020)
10.2 Global Imatinib Mesylate Revenue and Market Share by Type (2015-2020)
10.3 Global Imatinib Mesylate Price by Type (2015-2020)
11 Global Imatinib Mesylate Market Segment by Application
11.1 Global Imatinib Mesylate Sales Market Share by Application (2015-2020)
11.2 Global Imatinib Mesylate Revenue Market Share by Application (2015-2020)
11.3 Global Imatinib Mesylate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Imatinib Mesylate Sales, Revenue and Growth Rate (2021-2025)
12.2 Imatinib Mesylate Market Forecast by Regions (2021-2025)
12.2.1 North America Imatinib Mesylate Market Forecast (2021-2025)
12.2.2 Europe Imatinib Mesylate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Imatinib Mesylate Market Forecast (2021-2025)
12.2.4 South America Imatinib Mesylate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Imatinib Mesylate Market Forecast (2021-2025)
12.3 Imatinib Mesylate Market Forecast by Type (2021-2025)
12.3.1 Global Imatinib Mesylate Sales Forecast by Type (2021-2025)
12.3.2 Global Imatinib Mesylate Market Share Forecast by Type (2021-2025)
12.4 Imatinib Mesylate Market Forecast by Application (2021-2025)
12.4.1 Global Imatinib Mesylate Sales Forecast by Application (2021-2025)
12.4.2 Global Imatinib Mesylate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Imatinib Mesylate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Imatinib Mesylate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Imatinib Mesylate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GLEEVEC Basic Information, Manufacturing Base and Competitors
Table 8. GLEEVEC Imatinib Mesylate Major Business
Table 9. GLEEVEC Imatinib Mesylate Total Revenue (USD Million) (2017-2018)
Table 10. GLEEVEC SWOT Analysis
Table 11. GLEEVEC Imatinib Mesylate Product and Services
Table 12. GLEEVEC Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Nanjing Kaihua Chemical Basic Information, Manufacturing Base and Competitors
Table 14. Nanjing Kaihua Chemical Imatinib Mesylate Major Business
Table 15. Nanjing Kaihua Chemical Imatinib Mesylate Total Revenue (USD Million) (2017-2018)
Table 16. Nanjing Kaihua Chemical SWOT Analysis
Table 17. Nanjing Kaihua Chemical Imatinib Mesylate Product and Services
Table 18. Nanjing Kaihua Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 20. Cayman Chemical Imatinib Mesylate Major Business
Table 21. Cayman Chemical Imatinib Mesylate Total Revenue (USD Million) (2017-2018)
Table 22. Cayman Chemical SWOT Analysis
Table 23. Cayman Chemical Imatinib Mesylate Product and Services
Table 24. Cayman Chemical Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sichuan Xieli Basic Information, Manufacturing Base and Competitors
Table 26. Sichuan Xieli Imatinib Mesylate Major Business
Table 27. Sichuan Xieli Imatinib Mesylate Total Revenue (USD Million) (2017-2018)
Table 28. Sichuan Xieli SWOT Analysis
Table 29. Sichuan Xieli Imatinib Mesylate Product and Services
Table 30. Sichuan Xieli Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Zhengda Tianqing Basic Information, Manufacturing Base and Competitors
Table 32. Zhengda Tianqing Imatinib Mesylate Major Business
Table 33. Zhengda Tianqing Imatinib Mesylate Total Revenue (USD Million) (2017-2018)
Table 34. Zhengda Tianqing SWOT Analysis
Table 35. Zhengda Tianqing Imatinib Mesylate Product and Services
Table 36. Zhengda Tianqing Imatinib Mesylate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Imatinib Mesylate Sales by Manufacturer (2018-2019) (MT)
Table 38. Global Imatinib Mesylate Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Imatinib Mesylate Sales by Regions (2015-2020) (MT)
Table 40. Global Imatinib Mesylate Sales Market Share by Regions (2015-2020)
Table 41. Global Imatinib Mesylate Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Imatinib Mesylate Sales by Countries (2015-2020) (MT)
Table 43. North America Imatinib Mesylate Sales Market Share by Countries (2015-2020)
Table 44. North America Imatinib Mesylate Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Imatinib Mesylate Revenue Market Share by Countries (2015-2020)
Table 46. Europe Imatinib Mesylate Sales by Countries (2015-2020) (MT)
Table 47. Europe Imatinib Mesylate Sales Market Share by Countries (2015-2020)
Table 48. Europe Imatinib Mesylate Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Imatinib Mesylate Sales by Regions (2015-2020) (MT)
Table 50. Asia-Pacific Imatinib Mesylate Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Imatinib Mesylate Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Imatinib Mesylate Sales by Countries (2015-2020) (MT)
Table 53. South America Imatinib Mesylate Sales Market Share by Countries (2015-2020)
Table 54. South America Imatinib Mesylate Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Imatinib Mesylate Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Imatinib Mesylate Sales by Countries (2015-2020) (MT)
Table 57. Middle East & Africa Imatinib Mesylate Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Imatinib Mesylate Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Imatinib Mesylate Revenue Market Share by Countries (2015-2020)
Table 60. Global Imatinib Mesylate Sales by Type (2015-2020) (MT)
Table 61. Global Imatinib Mesylate Sales Share by Type (2015-2020)
Table 62. Global Imatinib Mesylate Revenue by Type (2015-2020) (USD Million)
Table 63. Global Imatinib Mesylate Revenue Share by Type (2015-2020)
Table 64. Global Imatinib Mesylate Sales by Application (2015-2020) (MT)
Table 65. Global Imatinib Mesylate Sales Share by Application (2015-2020)
Table 66. Global Imatinib Mesylate Sales Forecast by Regions (2021-2025) (MT)
Table 67. Global Imatinib Mesylate Market Share Forecast by Regions (2021-2025)
Table 68. Global Imatinib Mesylate Sales Forecast by Type (2021-2025) (MT)
Table 69. Global Imatinib Mesylate Market Share Forecast by Type (2021-2025)
Table 70. Global Imatinib Mesylate Sales Forecast by Application (2021-2025)
Table 71. Global Imatinib Mesylate Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Imatinib Mesylate Picture
Figure 2. Global Sales Market Share of Imatinib Mesylate by Type in 2019
Figure 3. 99% Purity Picture
Figure 4. 98% Purity Picture
Figure 5. Other Picture
Figure 6. Imatinib Mesylate Sales Market Share by Application in 2018
Figure 7. CML Picture
Figure 8. GIST Picture
Figure 9. Other Picture
Figure 10. Global Imatinib Mesylate Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Imatinib Mesylate Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Imatinib Mesylate Sales Market Share by Manufacturer in 2019
Figure 31. Global Imatinib Mesylate Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Imatinib Mesylate Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Imatinib Mesylate Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Imatinib Mesylate Revenue Market Share by Regions (2015-2020)
Figure 38. Global Imatinib Mesylate Revenue Market Share by Regions in 2018
Figure 39. North America Imatinib Mesylate Sales and Growth Rate (2015-2020)
Figure 40. Europe Imatinib Mesylate Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Imatinib Mesylate Sales and Growth Rate (2015-2020)
Figure 42. South America Imatinib Mesylate Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Imatinib Mesylate Sales and Growth Rate (2015-2020)
Figure 44. North America Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Imatinib Mesylate Sales Market Share by Countries (2015-2020)
Figure 46. North America Imatinib Mesylate Sales Market Share by Countries in 2018
Figure 47. North America Imatinib Mesylate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Imatinib Mesylate Revenue Market Share by Countries in 2018
Figure 49. United States Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Imatinib Mesylate Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Imatinib Mesylate Revenue Market Share by Countries in 2019
Figure 55. Germany Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Imatinib Mesylate Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Imatinib Mesylate Revenue Market Share by Regions 2019
Figure 63. China Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Imatinib Mesylate Sales Market Share by Countries in 2019
Figure 70. South America Imatinib Mesylate Revenue Market Share by Countries in 2019
Figure 71. Brazil Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Imatinib Mesylate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Imatinib Mesylate Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Imatinib Mesylate Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Imatinib Mesylate Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Imatinib Mesylate Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Imatinib Mesylate Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Imatinib Mesylate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Imatinib Mesylate Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Imatinib Mesylate Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Imatinib Mesylate Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Imatinib Mesylate Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Imatinib Mesylate Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel